FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206083170> ?p ?o ?g. }

• W4206083170 endingPage "108946" @default.
• W4206083170 startingPage "108946" @default.
• W4206083170 abstract "Chemokines and adhesion molecules are major inflammatory mediators of chronic and recurrent vernal keratoconjunctivitis (VKC). Sulforaphane (SFN) is a natural plant extract that is known to have anti-inflammatory and antioxidant properties. SFN is demonstrated to be effective against a variety of human diseases. The current investigation examines the effects and the molecular mechanisms of SFN on cytokine-induced human corneal fibroblasts (HCFs) expression of adhesion molecules and chemokines. HCFs were exposed to both interleukin (IL)-4 and tumor necrosis factor (TNF)-α in the absence or presence of SFN treatment. The levels of thymus- and activation-regulated chemokine (TARC) and eotaxin-1 in culture supernatants were evaluated using enzyme-linked immunosorbent assay (ELISA). Reverse transcription-polymerase chain reaction analysis (RT-PCR) enabled quantification of mRNA levels of vascular cell adhesion molecule (VCAM)-1, eotaxin-1, and TARC along with cytokine receptors. An immunoblotting assay was used to evaluate the activities of VCAM-1, nuclear factor-kappa B (NF-κB), mitogen-activated protein kinases (MAPKs), signal transducer and activator of transcription factor (STAT)6 pathways, along with the expression of the cytokine receptors including IL-4 receptor (R)α, IL-13Rα1, TNFRI, as well as TNFRII. SFN inhibited TARC and eotaxin-1 release in HCFs stimulated by TNF-α and IL-4 in a manner dependent on dose and time. SFN suppressed transcriptions of TARC, eotaxin-1, and VCAM-1. Furthermore, the mRNA and protein expression levels of IL-4Rα, TNFRI, and TNFRII were also attenuated by SFN exposure, however, those of IL-13Rα1 remained unaffected. In addition, SFN downregulated the expression of VCAM-1 and the phosphorylation of MAPKs, IκBα, and STAT6. These results suggest that SFN inhibited cytokine-stimulated TARC, eotaxin-1 secretion as well as VCAM-1 expression in HCFs, with these effects likely occurring as a result of cytokine receptor inhibition and attenuation of MAPK, NF-κB, and STAT6 signaling. SFN may therefore have therapeutic potential in VKC treatment." @default.
• W4206083170 created "2022-01-26" @default.
• W4206083170 creator A5018742393 @default.
• W4206083170 creator A5023363049 @default.
• W4206083170 creator A5031984957 @default.
• W4206083170 creator A5032715719 @default.
• W4206083170 creator A5057596529 @default.
• W4206083170 creator A5062028483 @default.
• W4206083170 creator A5067641905 @default.
• W4206083170 date "2022-03-01" @default.
• W4206083170 modified "2023-10-16" @default.
• W4206083170 title "Sulforaphane inhibits cytokine-stimulated chemokine and adhesion molecule expressions in human corneal fibroblasts: Involvement of the MAPK, STAT, and NF-κB signaling pathways" @default.
• W4206083170 cites W1968734923 @default.
• W4206083170 cites W1972995842 @default.
• W4206083170 cites W1980774686 @default.
• W4206083170 cites W1990960106 @default.
• W4206083170 cites W2001851523 @default.
• W4206083170 cites W2012893538 @default.
• W4206083170 cites W2022689552 @default.
• W4206083170 cites W2032507581 @default.
• W4206083170 cites W2039999853 @default.
• W4206083170 cites W2045873742 @default.
• W4206083170 cites W2058266118 @default.
• W4206083170 cites W2074545228 @default.
• W4206083170 cites W2084455686 @default.
• W4206083170 cites W2091726616 @default.
• W4206083170 cites W2139666950 @default.
• W4206083170 cites W2148503984 @default.
• W4206083170 cites W2313393770 @default.
• W4206083170 cites W2471034504 @default.
• W4206083170 cites W2558688131 @default.
• W4206083170 cites W2587871687 @default.
• W4206083170 cites W2626340515 @default.
• W4206083170 cites W2793893358 @default.
• W4206083170 cites W2901712937 @default.
• W4206083170 cites W2943031668 @default.
• W4206083170 cites W2945446419 @default.
• W4206083170 cites W3003385350 @default.
• W4206083170 cites W3006172149 @default.
• W4206083170 cites W3034517410 @default.
• W4206083170 cites W3035768906 @default.
• W4206083170 cites W3036556358 @default.
• W4206083170 cites W3084351262 @default.
• W4206083170 cites W3097573534 @default.
• W4206083170 cites W3101182379 @default.
• W4206083170 cites W3173609248 @default.
• W4206083170 cites W4210995306 @default.
• W4206083170 cites W2946480957 @default.
• W4206083170 doi "https://doi.org/10.1016/j.exer.2022.108946" @default.
• W4206083170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35038457" @default.
• W4206083170 hasPublicationYear "2022" @default.
• W4206083170 type Work @default.
• W4206083170 citedByCount "2" @default.
• W4206083170 countsByYear W42060831702022 @default.
• W4206083170 countsByYear W42060831702023 @default.
• W4206083170 crossrefType "journal-article" @default.
• W4206083170 hasAuthorship W4206083170A5018742393 @default.
• W4206083170 hasAuthorship W4206083170A5023363049 @default.
• W4206083170 hasAuthorship W4206083170A5031984957 @default.
• W4206083170 hasAuthorship W4206083170A5032715719 @default.
• W4206083170 hasAuthorship W4206083170A5057596529 @default.
• W4206083170 hasAuthorship W4206083170A5062028483 @default.
• W4206083170 hasAuthorship W4206083170A5067641905 @default.
• W4206083170 hasConcept C12823836 @default.
• W4206083170 hasConcept C13373296 @default.
• W4206083170 hasConcept C153911025 @default.
• W4206083170 hasConcept C16224149 @default.
• W4206083170 hasConcept C170493617 @default.
• W4206083170 hasConcept C17991360 @default.
• W4206083170 hasConcept C185592680 @default.
• W4206083170 hasConcept C203014093 @default.
• W4206083170 hasConcept C2777716647 @default.
• W4206083170 hasConcept C2778690821 @default.
• W4206083170 hasConcept C502942594 @default.
• W4206083170 hasConcept C55493867 @default.
• W4206083170 hasConcept C62478195 @default.
• W4206083170 hasConcept C86803240 @default.
• W4206083170 hasConcept C95444343 @default.
• W4206083170 hasConceptScore W4206083170C12823836 @default.
• W4206083170 hasConceptScore W4206083170C13373296 @default.
• W4206083170 hasConceptScore W4206083170C153911025 @default.
• W4206083170 hasConceptScore W4206083170C16224149 @default.
• W4206083170 hasConceptScore W4206083170C170493617 @default.
• W4206083170 hasConceptScore W4206083170C17991360 @default.
• W4206083170 hasConceptScore W4206083170C185592680 @default.
• W4206083170 hasConceptScore W4206083170C203014093 @default.
• W4206083170 hasConceptScore W4206083170C2777716647 @default.
• W4206083170 hasConceptScore W4206083170C2778690821 @default.
• W4206083170 hasConceptScore W4206083170C502942594 @default.
• W4206083170 hasConceptScore W4206083170C55493867 @default.
• W4206083170 hasConceptScore W4206083170C62478195 @default.
• W4206083170 hasConceptScore W4206083170C86803240 @default.
• W4206083170 hasConceptScore W4206083170C95444343 @default.
• W4206083170 hasFunder F4320321001 @default.
• W4206083170 hasLocation W42060831701 @default.
• W4206083170 hasLocation W42060831702 @default.
• W4206083170 hasOpenAccess W4206083170 @default.
• W4206083170 hasPrimaryLocation W42060831701 @default.

• next